Alaunos Therapeutics, Inc. (NASDAQ:TCRT)
Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
Loses money on what it sells.
- Revenue
- $3K
- Net income
- -$4.0M
- Net margin
- -133666.7%
Little or no net debt.
- Total debt
- $0
- Cash
- $124K
- Debt / equity
- 0.00
Owes more within a year than it holds to pay it.
- Current assets
- $666K
- Current liabilities
- $864K
- Current ratio
- 0.77
Consumes cash and must keep raising it.
- Operating cash flow
- -$2.7M
- Free cash flow
- -$2.8M
- FCF margin
- -94166.6%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 2.4M
- Share growth (1y)
- 45.1%
- Cash runway
- 1 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
TCRT Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 3.00 K | 0.00 | 0.00 | 2.00 K |
| Revenue Growth (YoY) | — | -100.00 % | -25.00 % | — | -100.00 % | 100.00 % |
| Cost of Revenue | 9.00 K | 8.00 K | 361.00 K | 469.00 K | 185.00 K | 347.00 K |
| Gross Profit | -9.00 K | -8.00 K | -358.00 K | -469.00 K | -185.00 K | -345.00 K |
| SG&A Expense | 564.00 K | 585.00 K | 549.00 K | 718.00 K | 854.00 K | 747.00 K |
| R&D Expense | 388.00 K | 427.00 K | 361.00 K | 469.00 K | 185.00 K | 347.00 K |
| Operating Expenses | 943.00 K | 1.00 M | 549.00 K | 718.00 K | 854.00 K | 747.00 K |
| Operating Income | -952.00 K | -1.01 M | -907.00 K | -1.19 M | -1.04 M | -1.09 M |
| Pretax Income | -952.00 K | -1.01 M | -893.00 K | -1.16 M | -1.05 M | -1.07 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -952.00 K | -1.01 M | -893.00 K | -1.16 M | -1.05 M | -1.07 M |
| EPS (Basic) | -0.41 | -0.59 | -0.40 | -0.55 | -0.63 | -0.67 |
| EPS (Diluted) | -0.41 | -0.59 | -0.40 | -0.55 | -0.63 | -0.67 |
| Shares Outstanding | 2.43 M | 1.95 M | 1.95 M | 2.18 M | 1.68 M | 1.60 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.